Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in ...

Mylan appealed from a Patent Trial and Appeal Board (Board) discretionary denial of institution of an inter partes review (IPR) proceeding. The Board declined to institute Mylan’s IPR under NHK-Fintiv ...

A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat the opioid crisis across the nation. Under the tentative settlement, Mylan ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. said Wednesday it will reorganize following its acquisition of a controlling interest in Matrix Laboratories. The company said Chief Scientific ...

“[W]e are aware of no ‘history or tradition’ that supports a fundamental right to have the Board consider whether to institute one’s IPR petition based solely upon co-pending litigation to which you ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

Mylan Laboratories said on Monday it agreed to acquire troubled drugmaker King Pharmaceuticals Inc. for about $4 billion, adding patent-protected brand drugs to Mylan’s generic-drug offerings. Under ...

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

NEW YORK, Jan 31 (Reuters) - Mylan Laboratories Inc. said on Wednesday it was reorganizing its executive ranks after acquiring a controlling interest in India's Matrix Laboratories Ltd. , and that ...